These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1448 related items for PubMed ID: 17606567

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM, Araneta MR, Deville JG, Spector SA.
    Clin Infect Dis; 2004 Sep 01; 39(5):725-31. PubMed ID: 15356789
    [Abstract] [Full Text] [Related]

  • 5. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART.
    Chiappini E, Galli L, Tovo PA, Gabiano C, Lisi C, Gattinara GC, Esposito S, Viganò A, Giaquinto C, Rosso R, Guarino A, de Martino M.
    AIDS; 2007 Jul 31; 21(12):1607-15. PubMed ID: 17630556
    [Abstract] [Full Text] [Related]

  • 6. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.
    Infection; 2005 Oct 31; 33(5-6):345-9. PubMed ID: 16258865
    [Abstract] [Full Text] [Related]

  • 7. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ, Gazzard BG, Easterbrook PJ.
    J Infect; 2001 Feb 31; 42(2):134-9. PubMed ID: 11531320
    [Abstract] [Full Text] [Related]

  • 8. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E.
    Parassitologia; 2004 Jun 31; 46(1-2):89-93. PubMed ID: 15305694
    [Abstract] [Full Text] [Related]

  • 9. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).
    Guillén S, García San Miguel L, Resino S, Bellón JM, González I, Jiménez de Ory S, Muñoz-Fernández MA, Navarro ML, Gurbindo MD, de José MI, Mellado MJ, Martín-Fontelos P, Gonzalez-Tomé MI, Martinez J, Beceiro J, Roa MA, Ramos JT, Madrid Group for Research on Pediatric HIV Infection.
    HIV Med; 2010 Apr 31; 11(4):245-52. PubMed ID: 20050937
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B, Mocroft A, Reiss P, Furrer H, Kirk O, Bickel M, Uberti-Foppa C, Pradier C, D'Arminio Monforte A, Schneider MM, Lundgren JD, Eight European Study Groups.
    N Engl J Med; 2001 Jan 18; 344(3):168-74. PubMed ID: 11188837
    [Abstract] [Full Text] [Related]

  • 12. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
    Werneck-Silva AL, Prado IB.
    J Gastroenterol Hepatol; 2009 Jan 18; 24(1):135-9. PubMed ID: 19054257
    [Abstract] [Full Text] [Related]

  • 13. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS.
    Infection; 2008 Jun 18; 36(3):231-6. PubMed ID: 18463787
    [Abstract] [Full Text] [Related]

  • 14. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.
    Buchacz K, Baker RK, Moorman AC, Richardson JT, Wood KC, Holmberg SD, Brooks JT, HIV Outpatient Study (HOPS) Investigators.
    AIDS; 2008 Jul 11; 22(11):1345-54. PubMed ID: 18580614
    [Abstract] [Full Text] [Related]

  • 15. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T, Ratanasuwan W, Techasathit W, Rongrungruang Y, Suwanagool S.
    J Med Assoc Thai; 2004 Feb 11; 87(2):173-9. PubMed ID: 15061301
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.
    Kline MW, Rugina S, Ilie M, Matusa RF, Schweitzer AM, Calles NR, Schwarzwald HL.
    Pediatrics; 2007 May 11; 119(5):e1116-20. PubMed ID: 17420261
    [Abstract] [Full Text] [Related]

  • 17. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
    Sogaard OS, Lohse N, Gerstoft J, Kronborg G, Ostergaard L, Pedersen C, Pedersen G, Sørensen HT, Obel N.
    Clin Infect Dis; 2008 Nov 15; 47(10):1345-53. PubMed ID: 18834317
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.
    Jordano Q, Falcó V, Almirante B, Planes AM, del Valle O, Ribera E, Len O, Pigrau C, Pahissa A.
    Clin Infect Dis; 2004 Jun 01; 38(11):1623-8. PubMed ID: 15156452
    [Abstract] [Full Text] [Related]

  • 20. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
    Esposito S, Porta A, Bojanin J, Gualtieri L, Cesati L, Vismara E, Principi N.
    Eye (Lond); 2006 May 01; 20(5):595-7. PubMed ID: 16410815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.